NDC 71610-726
Lisinopril 2.5 mg tablet
On the label: Aphena Pharma Solutions - Tennessee, Inc.. It's repackaged: Aphena Pharma Solutions - Tennessee, Inc. rebottles it from Lupin Pharmaceuticals, Inc.'s NDC 68180-512.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Lupin Limited | Salcette, India | Makes it and packages it | Problems found, fixed voluntarilyNov 21, 2025 · 9 inspections, 1 with FDA action |
| Lupin Limited | Pithampur, India | Makes it and packages it | Serious problems, FDA actionJul 17, 2025 · 6 inspections, 4 with FDA action |
| Lupin Limited | Nagpur, India | Makes it and packages it | Problems found, fixed voluntarilyJul 11, 2023 · 4 inspections |
Repackaging site
- Aphena Pharma Solutions - Tennessee, LLC, Cookeville, TN, United States · repackages it
Recalls
- Sep 13, 2022 · Class II · Lupin Pharmaceuticals Inc.
Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.
Lots: Lot # Q201182, exp. date March 2024 - May 28, 2020 · Class II · Lupin Pharmaceuticals Inc.
Product Mix Up: Lisinopril 10 mg tablets were found in Lisinopril 5 mg 1000-count bottle.
Lots: Lot # Q900683, Exp. 10/31/2022 - Apr 1, 2020 · Class II · Lupin Pharmaceuticals Inc.
Presence of Foreign Tablet/ Capsule: Product complaint received indicating mix-up of one lisinopril 5mg tablet inside of a 30 mg, 100-count bottle of Lisinopril Tablets.
Lots: Lot #: Q900580, Exp 9/2021 - Aug 13, 2018 · Class II · Lupin Pharmaceuticals Inc.
Presence of Foreign Substance: Product complaint was received of metal contaminant observed in one tablet.
Lots: Lot #: H800414, Exp. 12/2019 - Apr 6, 2016 · Class III · Lupin Pharmaceuticals Inc.
CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications.
Lots: Batch number: H303487, H303488, H303489, Exp 09/16 - Apr 6, 2016 · Class III · Lupin Pharmaceuticals Inc.
CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications.
Lots: Batch number: H303449, Exp 09/16
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Lisinopril: every company that makes it
- Form
- tablet, oral
- Strength
- 2.5 mg
- Approval
- ANDA ANDA077321
- On the market since
- Jan 13, 2006
- Package NDCs
71610-726-3071610-726-4571610-726-5371610-726-6071610-726-70- Official label
- DailyMed (National Library of Medicine), updated Aug 18, 2023
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?